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Proteins containing “cold shock” domains belong to the most evolutionarily conserved family of nucleic
acid-binding proteins known among bacteria, plants, and animals. One of these proteins, YB-1, is widely
expressed throughout development and has been implicated as a cell survival factor that regulates the
transcription and/or translation of many cellular growth and death-related genes. For these reasons, YB-1
deficiency has been predicted to be incompatible with cell survival. However, the majority of YB-1/ embryos
develop normally up to embryonic day 13.5 (E13.5). After E13.5, YB-1/ embryos exhibit severe growth
retardation and progressive mortality, revealing a nonredundant role of YB-1 in late embryonic development.
Fibroblasts derived from YB-1/ embryos displayed a normal rate of protein synthesis and minimal alter-
ations in the transcriptome and proteome but demonstrated reduced abilities to respond to oxidative, geno-
toxic, and oncogene-induced stresses. YB-1/ cells under oxidative stress expressed high levels of the G1-
specific CDK inhibitors p16Ink4a and p21Cip1 and senesced prematurely; this defect was corrected by
knocking down CDK inhibitor levels with specific small interfering RNAs. These data suggest that YB-1
normally represses the transcription of CDK inhibitors, making it an important component of the cellular
stress response signaling pathway.
Over the past decade, an increasing number of multifunc-
tional regulatory factors that control gene expression at both
the transcriptional and posttranscriptional levels have been
described. Human YB-1 and its vertebrate homologues are
one example. YB-1 belongs to a large family of proteins that
contain a conserved nucleic acid-binding domain termed the
cold shock domain (CSD), which shares about 40% amino acid
sequence identity with bacterial cold shock proteins. Among
the CSD family of proteins, YB-1 and its orthologues consti-
tute an exceptionally conserved subfamily that contains nearly
identical amino acid sequences for the whole molecule (98%
identity between the human and mouse proteins). While sev-
eral members were initially identified as DNA-binding proteins
that interacted specifically with a conserved cis-regulatory Y-
box element, YB-1 proteins have since been shown to bind
avidly in vitro to a wide variety of forms of nucleic acids,
including pyrimidine-rich single-stranded DNA, triplex/single-
stranded H-DNA, damaged DNA, and RNA (references 18
and 36 and references therein).
Based on its broad nucleic acid-binding properties, a myriad
of cellular functions have been ascribed to YB-1. In mamma-
lian cells, YB-1 has been shown to shuttle between the nuclear
and cytoplasmic compartments (reference 25 and references
therein). Within the nucleus, YB-1 interacts directly with other
DNA- and pre-mRNA-binding proteins such as p53, AP2,
CTCF, hnRNP K, and SRp30c (for a complete list, see a recent
review [20]). To date, YB-1 has been implicated in nuclear
activities such as chromatin remodeling, transcriptional regu-
lation, DNA repair, and pre-mRNA splicing/transport (11).
YB-1 is also abundant in the cytoplasm, where it is a major
structural component of messenger ribonucleoprotein com-
plexes and may act as an mRNA chaperone (6, 9) and a
regulator of translation (reference 1 and references therein).
Thus, YB-1 has been proposed to function as a multifunctional
coordinator for the control of gene expression in both the
nucleus and the cytoplasm (20, 34).
YB-1 is broadly expressed throughout development, and its
expression level closely correlates with the cell proliferation
state. YB-1 is abundantly expressed in early chicken and rat
embryos, and its level decreases steadily during development
(15, 19). High levels of YB-1 are also detected in vivo in
actively proliferating adult tissues such as the colorectal epi-
thelial glands (29) and regenerating liver tissue following
chemical-induced damage (15) or hepatectomy (19). YB-1 is
induced in various cell types in response to mitogenic stimuli,
such as cytokine-stimulated T cells (27), serum-activated fibro-
blasts (19), and agonist-stimulated endothelial cells (31). Fur-
thermore, increased nuclear and/or cytoplasmic expression of
YB-1 has frequently been detected in a wide range of human
cancers, including breast, ovarian, thyroid, and colorectal can-
cers, osteosarcomas, and synovial sarcomas (reviewed in ref-
erence 20). Similar results have also been described for exper-
imental systems such as mouse and rabbit cancers (reviewed in
reference 21). Importantly, an association of elevated levels of
YB-1 and tumor progression has been reported for melanoma
and also for lung, squamous cell, and prostate cancers (21).
These clinical observations have suggested that disregulated
expression of YB-1 may be associated with unfavorable clinical
outcomes. However, it remains unclear whether YB-1 overex-
* Corresponding author. Mailing address: Division of Oncology,
Section of Stem Cell Biology, Campus Box 8007, 660 South Euclid
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pression is causally related to the malignant phenotype or is
simply a “marker” associated with rapid cell growth. Further-
more, the normal physiological role of YB-1 has yet to be de-
fined, since knockout mice have been difficult to generate (28).
To better understand the physiological functions of YB-1 in
vivo, we created homozygous mice with a true null mutation in
the YB-1 gene. An analysis of YB-1-deficient animals revealed
that YB-1 is required for the normal development of multiple
embryonic organ systems and for perinatal survival. YB-1 plays
an important role in cellular stress responses and in the pre-
vention of premature senescence in cultured primary cells.
YB-1 is therefore essential for early mammalian development
and important for cellular responses to a variety of stresses.
MATERIALS AND METHODS
Generation of YB-1/ mice. The left arm of the targeting vector consisted of
a 3.2-kb HindIII fragment containing YB-1 exons 1 and 2. The right arm was a
5.5-kb EcoRI fragment containing exons 4 to 6 and the 5 portion of exon 7. The
left arm, the PGK-neo cassette, and the right arm were cloned in the proper
orientation into pCR2.1 (Invitrogen). The targeting vector was linearized with
XhoI and electroporated into RW4 embryonic stem (ES; 129/SvJ) cells. G418-
resistant clones were isolated and screened for homologous recombination by
Southern analysis (Fig. 1A). A 5 external probe (probe A) detected a 5.3-kb
wild-type or 3.5-kb mutant allele in EcoRI-digested ES cell genomic DNAs.
Correct targeting at the 3 end was analyzed by Southern blotting with an internal
probe (probe B). The wild-type allele generated a 9.2-kb BstXI fragment, and the
mutant generated an 8.3-kb fragment. Targeted ES cell clones were injected into
C57BL/6 mouse blastocysts to generate chimeras. To obtain pure 129/SvJ mice,
we crossed chimeric males with 129/SvJ females to derive F1 YB-1/ mice. To
derive embryos of each YB-1 genotype, we intercrossed YB-1/ females with
YB-1/ males and designated the time for detection of a vaginal copulation plug
as embryonic day 0.5 (E0.5).
MEF preparation and culture. Mouse embryonic fibroblasts (MEFs) were
dissociated from E13.5 embryos with trypsin and then cultured in Dulbecco’s
modified Eagle’s medium (Cellgro and Sigma) containing 10% heat-inactivated
fetal calf serum, 1 mM sodium pyruvate, 1 mM nonessential amino acids, and 100
U/ml penicillin and streptomycin in 5% CO2 at 37°C. For serial passaging, cells
were maintained according to a protocol in which 8  105 cells were seeded per
T-25 flask (or equivalent) every 3 days (3T8 protocol). For growth curve assays,
MEFs were seeded at 3.0  104 cells per 12-well plate and grown for up to 12
days. MEFs were also cultured in 3% O2–5% CO2 in a hypoxia chamber (Stem-
Cell Technologies) at 37°C. The chamber was flushed with 3% O2–5% CO2 every
24 h. For synchronization of the MEFs at the G0 phase, log-phase MEFs were
washed twice with phosphate-buffered saline and incubated in Dulbecco’s mod-
ified Eagle’s medium supplemented with 0.1% fetal calf serum for 3 days, with
the medium being changed daily. To test their sensitivity to genotoxic drugs, we
seeded MEFs at 3.0  104 cells per 12-well plate and allowed them to attach by
FIG. 1. Targeted disruption of YB-1 gene. (A) Diagram of mouse YB-1 genomic locus, targeting vector, and targeted locus. E, EcoRI; B, BstXI.
(B) Southern blot analysis of genomic DNAs derived from embryos of YB-1/ intercross. WT, wild-type allele; KO, targeted allele. (C) Real-time
quantitative RT-PCR analysis of YB-1 and MSY4 mRNA expression. The data shown are mean values with standard deviations for three wild-type,
three YB-1/, or five YB-1/ samples (***, P  0.001). (D) Western blot analysis of whole-cell lysates from MEFs of each genotype with YB-1-,
MSY4-, and -actin-specific antibodies.
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incubating overnight. The cells were then exposed to various doses of drugs (see
Fig. 4C) for 3 h, washed with medium, and cultured for 3 more days before being
counted. Cell growth was expressed as a percentage of the growth by control
MEFs of each genotype without drugs.
BrdU incorporation, 35S incorporation, and senescence-associated -galacto-
sidase (SA--Gal) assay. For 5-bromo-2-deoxyuridine (BrdU) labeling, MEFs
were incubated in culture medium containing 10 M BrdU (Roche) for 30 min
at 37°C and then processed as suggested by the kit manufacturer.
For determination of the rate of protein synthesis, cells were washed twice with
labeling medium (MP Biochemicals) and then incubated in the same medium
containing 30 to 100 Ci/ml Trans[35S] label (MP Biomedicals) for 30 min at
37°C. To inhibit protein synthesis, we allowed the labeling reaction to proceed in
the presence of 50 g/ml cycloheximide (Sigma). For determination of the
amount of 35S label incorporation, the samples were harvested, total cell num-
bers were counted, and then the samples were treated with trichloroacetic acid
(TCA). The radioactivity present in the TCA precipitates was measured by liquid
scintillation counting and normalized to the cell number.
The SA--Gal activity at pH 6.0 was assayed by flow cytometry using an
ImaGene Green C12FDG lacZ gene expression kit as described by the manu-
facturer (Molecular Probes), with small modifications. Briefly, harvested cells
were fixed for 3 min with 3% formaldehyde at room temperature, washed with
phosphate-buffered saline, stained for 1 h with the SA--Gal stain solution
described by Dimri et al. (7), using C12FDG in place of X-Gal (5-bromo-4-
chloro-3-indolyl--D-galactopyranoside), and immediately analyzed with a FAC-
Scan cytometer.
Antibodies and Western analysis. We generated rabbit antisera against a
mouse YB-1 peptide (QPREDGNEEDKEN; residues 252 to 264) and an MSY4
peptide (NRMQAGEIGEMKDGV; residues 249 to 263). Additional primary
antibodies used were anti-actin (C-20; Santa Cruz), anti-p16Ink4a (M-156; Santa
Cruz), anti-p21Cip1 (Ab-6; Oncogene), anti-Mdm2 (SMP-149; Santa Cruz), anti-
p53 (Ab-7; Oncogene), and anti-green fluorescent protein (anti-GFP) (fl-1;
Santa Cruz). Western blotting was performed according to a standard procedure
(18) or as recommended by the suppliers, and proteins were detected by en-
hanced chemiluminescence using the ECL detection system (Amersham).
Lentivirus production and infection and small interfering RNA (siRNA) in-
fection. A YB-1–GFP fusion cDNA was created by cloning the human YB-1
cDNA into HindIII and BamHI sites of pEGFP-N1 (Clontech) and subcloning
this vector into a lentiviral transfer vector. To infect MEFs with the virus, we
incubated 2  105 log-phase cells in media containing different virus titers, and
we analyzed the efficiency of infection by determining the percentage of GFP
cells with a FACScan cytometer at 2 days postinfection.
The sense sequence of the siRNA specific for p16Ink4a was 5-GGAGUCC
GCUGCAGACAGAdAdT-3, which is encoded by exon 1 of the gene. The
sense sequence of the siRNA for a knockdown p21Cip1 mRNA was 5-AACG
GUGGAACUUUGACUUCG-3 and was previously described (38). A nonspe-
cific control duplex with 47% GC content and UU overhangs which lacks ho-
mology with known gene targets (Dharmacon) was used as a nontargeting siRNA
control. siRNA transfection was performed as previously described (38).
Microarray and DIGE analysis. Total RNAs were isolated from passage 3
MEFs by use of an RNeasy kit (QIAGEN). Microarray probes were synthesized
by using individual RNA samples and were hybridized with Affymetrix mouse
MU74Av2 GeneChips at the Siteman Cancer Center Multiplexed Gene Analysis
Core. The data set was analyzed with the Significance Analysis of Microarrays
(SAM) program to identify transcripts that were differentially displayed among
YB-1/, YB-1/, and YB-1/ MEFs. Specifically, a two-class unpaired per-
mutation test using a twofold-change threshold was used to determine signifi-
cantly changed transcripts. A statistic tuning parameter (	 value) was used to
adjust the stringency of analysis (i.e., the predicted median false discovery rate
[up to 0.140]). Whole-cell lysates were prepared from passage 3 MEFs for
two-dimensional (2-D) differential in-gel electrophoresis (DIGE) analysis as
previously described (5).
RESULTS
Targeted inactivation of YB-1. To study the normal functions
of YB-1 in mice, we used homologous recombination to gen-
erate a true null allele of YB-1 in 129/SvJ mouse ES cells. The
strategy used to disrupt the gene is illustrated in Fig. 1A.
Homologous recombination between the targeting vector and
the YB-1 locus results in the replacement of a 9.5-kb genomic
region containing YB-1 exon 3 with a PGK-neo cassette. The
deleted exon 3 encodes a portion of the YB-1 CSD, and the
mutation also disrupts the coding frame of the gene. Two
correctly targeted clones were identified by Southern blot anal-
ysis (see Materials and Methods); both were injected into
C57BL/6 mouse blastocysts to generate chimeras. Germ line
transmission of the mutation was achieved by both lines of
chimeric males when they were bred with C57BL/6 female
mice. The two resultant mutant strains displayed the same
phenotypes, and both were used to obtain the data presented
in this report.
Embryos homozygous for the YB-1 targeted mutation were
recovered from YB-1/ intercross matings (Fig. 1B and 2A).
To measure the transcriptional output from the mutant allele,
we performed real-time quantitative RT-PCR analysis of total
RNAs derived from cells of individual embryos. Two primer
sets (one downstream and one upstream of the deleted exon 3)
gave similar results (Fig. 1C and data not shown). No YB-1
mRNA was detected in YB-1/ cells. YB-1/ samples
showed an approximately 50% reduction in the levels of YB-1
mRNA (P  0.001). Western blot analysis using an antibody
against a peptide C-terminal to the CSD revealed the complete
absence of the YB-1 protein in E13.5 YB-1/ embryos (Fig.
1D). The steady-state mRNA and protein levels of the MSY4
gene (a YB-1 paralogue coexpressed with YB-1 in developing
embryos) were not altered in YB-1/ or YB-1/ embryos
(Fig. 1C and D).
Disruption of YB-1 results in embryonic/perinatal lethality.
Mice heterozygous for the YB-1 mutation were phenotypically
indistinguishable from their wild-type littermates. However, no
homozygous pups were detected at weaning in a total of 482
progeny produced from 90 YB-1/ intercrosses (Fig. 2A, 129/
SvJ  C57BL/6, stage 3W). The ratio of YB-1/ to YB-1/
mice (164:318) was approximately 1:2. Similar results were
obtained from pure 129/SvJ YB-1/ matings (stage 3W).
Next, we sought to determine when the mortality of YB-1/
mice occurs. YB-1/ females used for intercross matings were
sacrificed at various gestational stages, genotypes of individual
embryos were determined by Southern blotting and PCR anal-
ysis, and the results are summarized in Fig. 2A. At embryonic
day 13.5 (E13.5), 4 of 39 homozygous embryos were nonviable,
as indicated by partial embryonic resorption or a lack of car-
diac activity and reflex motion. By E15.5, the fraction of non-
surviving YB-1/ embryos was 
27% (4/15). The majority of
homozygous embryos (14/18) were still alive near the end of
gestation (E18.5). In contrast, on postnatal day 1, the fre-
quency of homozygous neonates recovered was dramatically
underrepresented. Except for one newborn, none of the YB-
1/ mutants was alive at this stage. This observation supports
the hypothesis that most YB-1/ embryos that survived to
term died shortly after birth and were cannibalized.
As shown in Fig. 2B to I, YB-1/ embryos were generally
smaller than their wild-type and YB-1/ littermates. Embry-
onic growth retardation was detected in most living homozy-
gotes at E13.5 and was increasingly prominent at later stages.
By E18.5, the body weights of surviving homozygotes were 50
to 75% that of their wild-type and heterozygous littermates
(Fig. 2J). In addition, about one-third of the YB-1/ embryos
(21/72) also displayed craniofacial lesions, including improper
neural tube closure (Fig. 2C) and exencephaly (Fig. 2E, G, and
I). No such abnormalities were observed with wild-type em-
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bryos or heterozygotes. All embryos with craniofacial defects
were markedly pale, perhaps as a consequence of severe blood
loss from cerebral hemorrhage (Fig. 2H and I). Of these,
one-third (3/9) did not survive to E18.5, and the remainder
died shortly after C-section. The majority of E18.5 YB-1/
embryos without exencephaly (8/9) were initially alive but
quickly became cyanotic. Five of eight such neonates lost via-
bility within the first hour, whereas all wild-type (n  21) and
YB-1/ neonates (n  38) were viable at this point. Histolog-
ical analyses of serial embryo sections revealed that the alve-
olar spaces in the lungs of dead E18.5 (n  2) and P1 (n  1)
mutants were not inflated (data not shown). The other major
organ systems of these animals were small but grossly normal.
Taken together, these data suggest that neurological lesions,
severe hemorrhage, and respiratory failure at least partially
account for the observed embryonic/perinatal lethality.
FIG. 2. Phenotypes of YB-1/ embryos. (A) Genotypic and phenotypic distribution of progeny from YB-1/ intercross. The numbers of
embryos/neonates of each genotype at different stages of development are shown. The numbers of dead embryos/neonates are shown in
parentheses. E, embryonic stage in days; P1, postnatal day 1; 3W, 3 weeks after birth. †, this pup was small for its age but was alive 2 h after surgical
birth; ††, no wild-type or YB-1/ mice exhibited exencephaly. (B to I) Embryos at E13.5 (B and C), E15.5 (D and E), and E18.5 (F to I) stages
of development are shown. YB-1/ embryos exhibiting craniofacial defects are noted with arrows. (J) Body weights of embryos of each genotype
at different developmental stages. The data shown are mean values with standard deviations for 4 to 7 wild-type, 9 to 14 YB-1/, and 3 to 10
YB-1/ embryos (**, P  0.01). (K) Mean numbers of cells in fetal livers of four wild-type, four YB-1/, and four YB-1/ E15.5 embryos, with
standard deviations (**, P  0.01). (L) Flow cytometry-based morphological analysis of liver cells from one wild-type and one YB-1/ E15.5
embryo.
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Multiorgan hypoplasia in YB-1/ embryos. We next exam-
ined the organs of YB-1-deficient embryos to define the num-
ber and size of their constituent cells. The number of cells
recovered from E15.5 YB-1/ livers was about 50% that of
their wild-type and heterozygous counterparts (P  0.01; Fig.
2K). The undergrowth defect was not due to a developmental
arrest, since the onset of fetal/adult hematopoiesis occurred in
E13.5 YB-1/ livers without a noticeable delay (Z. H. Lu and
T. J. Ley, unpublished data). Similarly, there were about 40%
fewer cells recovered from trypsin-digested E13.5 YB-1/ car-
casses (embryos with neurological tissues and internal organs
removed [data not shown]). Flow cytometric analysis revealed
similar forward- versus side-scatter profiles for both fetal hepa-
tocytes (Fig. 2L) and fibroblasts (data not shown) obtained
from all embryos tested, suggesting that YB-1 deficiency does
not alter the size or granularity of these cell types in vivo. We
next performed terminal deoxynucleotidyltransferase-medi-
ated dUTP-biotin nick end labeling (TUNEL) assays on serial
cryo-sections of E18.5 embryos and found that the YB-1/
tissues contained normal numbers of TUNEL cells relative to
wild-type samples (data not shown). These data suggest that
YB-1/ embryos manifest growth retardation as a result of
multiorgan hypoplasia (a defect in cellular proliferation) with-
out detectable cellular hypotrophy (undergrowth of cell mass)
or increased apoptosis.
YB-1 deficiency does not cause “global” changes in the tran-
scriptome, proteome, or rate of protein synthesis in cells de-
rived from developing embryos. Since YB-1 has been proposed
to act as an important transcription/mRNA stability factor for
a variety of genes that could be relevant for embryonic devel-
opment, we performed a microarray analysis of cells derived
from individual embryos to identify genes with altered expres-
sion patterns due to the loss of YB-1. Total RNAs were isolated
from primary fibroblasts which had been freshly established
from E13.5 wild-type (n  2), YB-1/ (n  4), or YB-1/
(n  4) embryos (MEFs), labeled, and hybridized with Af-
fymetrix mouse MU74Av2 chips. The left panel of Fig. 3A
shows a scatter plot of the average signal of YB-1/ samples
for each probe set on the y axis, with corresponding average
wild-type signals shown on the x axis. The microarray data set
was analyzed with the SAM program to identify mRNAs
that were differentially displayed from MEFs derived from
YB-1//YB-1/ embryos (n  6) versus those from YB-1/
embryos (n  4) (Fig. 3A, right panel). Using nonstringent
parameters (with a twofold-change cutoff and a relaxed false
discovery rate [median  14%; 90% percentile  42%]), we
found that YB-1 itself displayed a greatly reduced abundance
(24-fold) in YB-1/ cells. Four mRNAs displayed a small
increase in abundance (more than twofold but less than three-
fold) (adenylyl cyclase-associated CAP protein homolog 1,
Gap junction membrane channel protein 2, translation elon-
gation factor 1 homolog 2, and cardiac -actin), and only one
other mRNA was reduced more than twofold (FMS-like ty-
rosine kinase 1). These results, together with the observation
that the total RNA yields per cell were indistinguishable
among all samples studied, strongly suggest that the transcrip-
tome is not globally altered in E13.5 embryonic tissues defi-
cient in YB-1.
We next performed a proteomic analysis of fibroblasts from
individual embryos to define alterations in steady-state protein
levels. Two sets of YB-1/ and wild-type MEFs which were
freshly derived from two independent litters were subjected to
2-D-DIGE analysis. Figure 3B shows a representative pair of
2-D gel profiles for one set of MEFs. Murine YB-1 (pI of 9.88)
was outside the range of proteins that were resolved on this
gel. With a cutoff of a twofold minimal change, the statistical
significance analysis failed to identify any protein spots that
were consistently different between two independent paired
sets.
YB-1 has been proposed to play a role in the global regula-
tion of mRNA translation. We therefore performed a trans-35S
label incorporation assay with freshly established MEFs. The
amount of protein synthesis in serum-starved or restimulated
YB-1/ MEFs was compared with that in wild-type MEFs
(Fig. 3C). The protein synthesis inhibitor cycloheximide was
used to verify that trans-35S label incorporation exclusively
measured protein synthesis. As shown in Fig. 3D, there was no
detectable difference in 35S label incorporation into proteins
(on a per cell basis) between freshly prepared quiescent YB-
1/ and wild-type MEFs. In addition, YB-1/ and wild-type
MEFs showed similar increases in 35S label incorporation in
response to mitogen stimulation.
YB-1/ MEFs display an elevated sensitivity to oxidative,
genotoxic, and oncogene-induced stresses. We next cultured
MEFs from individual E13.5 YB-1/ embryos to test the effect
of YB-1 deficiency on cellular growth in vitro under conditions
of oxidative stress (20% O2) or under “physiological” condi-
tions (3% O2) (24). MEFs were cultured and serially passaged
according to a 3T8 protocol, and their cell numbers were mon-
itored at the end of each passage. As expected, wild-type (Fig.
4A) and YB-1/ cells (data not shown) proliferated rapidly in
early passages but showed a steady decline in the rate of cell
growth in 20% O2. In contrast, YB-1
/ MEFs exhibited lower
cell densities throughout the early passages and entered com-
plete growth arrest as early as passage 4, two to three passages
earlier than the wild-type cells. In 3% O2, both wild-type and
YB-1/ MEFs showed significantly prolonged proliferative
life spans. As shown in Fig. 4B, a lower seeding density did not
release the growth arrest of YB-1/ cells grown in 20% O2
(passage 5), ruling out the possibility that an increased sensi-
tivity to contact inhibition (which is reversible) was responsi-
ble. In addition, YB-1/ MEFs also displayed an increased
sensitivity to the genotoxic drugs mitomycin C and cisplatin
compared with YB-1/ and YB-1/ MEFs (Fig. 4C), and
they had a reduced proliferative response to c-Myc overexpres-
sion (data not shown).
YB-1/ MEFs cultured in 20% O2 senesce prematurely. To
determine the effects of YB-1 deficiency under conditions of
oxidative stress, we subjected exponentially growing, asynchro-
nous passage 3 MEFs serially passaged in 20% O2 to flow
cytometric analysis to define their DNA contents. The extent
of apoptosis was evaluated by measuring the proportion of
cells containing sub-G0/G1 DNA content (Fig. 4D) and also by
assessing the number of nonadherent cells in the medium (data
not shown). No excess of apoptotic cells was detected in either
assay.
YB-1/ MEFs exhibited a slightly higher percentage of cells
in G0/G1, with a smaller proportion of cells in the S and G2/M
phases (Fig. 4D). To more precisely define the effects of YB-1
deficiency on cell cycle progression, we synchronized MEFs by
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serum starvation. The cells were then stimulated to reenter the
cell cycle by the addition of 10% serum. Growth factor depri-
vation did not cause a completely irreversible growth arrest in
YB-1-deficient cells (Fig. 4E), nor did it cause apoptosis (data
not shown). We next performed a BrdU pulse-labeling assay
with passage 3 MEFs to assess the timing of accumulation of
S-phase cells (Fig. 4F). After a lag phase of 8 to 12 h, the
wild-type cultures showed a steady increase in the proportion
of S-phase cells, so that by 16 h, 55% of the cells were in S
phase. In contrast, only a small proportion of YB-1/ cells
entered S phase at 12 h, and the percentage of YB-1/ cells in
S phase was consistently lower than that of wild-type cells for
FIG. 3. YB-1 deficiency does not cause “global” changes in transcriptome, proteome, or rate of protein synthesis in embryonic cells. (A) The
left panel is a scatter plot with the average signals for each probe set of YB-1/ samples (n  4) on the y axis and the average wild-type signals
(n  2) on the x axis. The position of YB-1 is shown. The right panel shows a SAM analysis of the microarray data set. Spots in green and red
represent genes that were significantly altered (more than twofold) in YB-1/ samples compared to wild-type and YB-1/ levels. (B) Proteomic
analysis by 2D-DIGE of YB-1/ and wild-type MEFs freshly established from embryos. (C) Diagram of 35S labeling experiment. CHX,
cycloheximide. (D) 35S label incorporation assay with serum-starved or restimulated MEFs, with or without cycloheximide. Data for four wild-type
and four YB-1/ MEF samples from two independent experiments are shown, with the incorporation normalized by cell number.
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up to 20 h. At this point, the majority of wild-type cells had
exited S phase.
We further examined the morphology of passage 4 YB-1/
MEFs that were serially passaged in 20% O2 and found that
most cells were large and flattened, a feature which is typical of
senescent fibroblasts in culture (Fig. 5A). YB-1/ MEFs also
accumulated higher levels of endogenous senescence-associ-
ated -galactosidase (SA--gal) activity (pH 6.0) than did wild-
type or YB-1/ cells (P  0.01) (Fig. 5B). Collectively, these
results suggest that YB-1/ MEFs have deceased proliferative
FIG. 4. YB-1/ MEFs showed increased sensitivity to oxidative, genotoxic, and c-Myc-induced stresses. (A) Serial passaging analysis of four
wild-type and four YB-1/ MEF samples in 20% or 3% O2. (B) Growth analysis of passage 5 MEFs serially cultured in 20% O2. Numbers refer
to mean values with standard deviations. (C) Relative growth of three wild-type, two YB-1/, and two YB-1/ MEF preparations exposed to
various doses of mitomycin C (MMC) and cisplatin, calculated and expressed as percentages of control MEFs of each genotype without drug
treatment (designated as 100%). (D) Flow cytometric analysis of cellular DNA contents (top) and flow cytometry-based analysis of cell morphology
using forward- and side-scatter (FSC-H and SSC-H) parameters (bottom). The cells with sub-G0/G1 DNA content are marked in red. (E) Growth
of serum-starved MEFs after addition of 10% serum. The numbers refer to mean values for five wild-type, five YB-1/, and five YB-1/ MEF
preparations from two independent experiments. (F) Analysis of percentages of BrdU-labeled MEFs after the addition of serum. Mean values with
standard deviations from two independent experiments are plotted. *, P  0.05; **, P  0.01.
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potential when cultured under oxidative stress because they
prematurely senesce.
To determine whether the growth phenotype of YB-1-defi-
cient MEFs is caused directly by the lack of this protein, we
examined the proliferative response of YB-1/ MEFs after
the reexpression of YB-1. We used a lentivirus to introduce a
PGK-driven YB-1–GFP fusion cDNA into passage 2 YB-1/
MEFs (Fig. 5C) and then cocultured the transgene-expressing
cell population with nonexpressing cells in a growth compe-
tition assay. A lentivirus that only expressed GFP was used
as a negative control. The expression of YB-1–GFP was
demonstrated by Western blot analysis using both YB-1- and
GFP-specific antibodies (Fig. 5D). In a typical experiment, the
infection of passage 2 MEFs with the YB-1–GFP- or GFP-
expressing virus resulted in 13 to 21% of the cells being marked
with green fluorescence (GFP) 2 days after infection (Fig.
5E). Thereafter, the cell cultures were subjected to serial pas-
saging, and the proportion of GFP cells was determined by
FIG. 5. Premature senescent phenotype of YB-1/ MEFs in 20% O2 is rescued by expression of YB-1–GFP. (A) Morphology of wild-type and
YB-1/ MEFs cultured in 20% O2 at passages 2 and 4 after Giemsa staining. (B) Flow cytometry-based analysis of SA--Gal activity in MEFs.
The data shown are mean fluorescence intensities of two wild-type, two YB-1/, and two YB-1/ MEF samples (from passages 2 and 4) from
two independent experiments. **, P  0.01. (C) Diagram of PGK-GFP and PGK–YB-1–GFP lentiviruses. (D) Western blot analysis of whole-cell
lysates from wild-type and YB-1/ MEFs infected with mock, GFP, or YB-1–GFP (YB-G) virus. YB-1-, GFP-, and -actin-specific antibodies were
used. (E) Serial passaging analysis of percentages of GFP cells from YB-1/ MEFs infected with GFP or YB-1–GFP lentivirus. The data plotted
are mean values (and standard deviations) for four independent YB-1/ MEF preparations from two independent experiments. *, P  0.05;
**, P 0.01. (F) Fluorescence and phase-contrast microscopic analysis of wild-type and YB-1/ passage 4 MEFs infected with GFP or YB-1–GFP
lentivirus.
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flow cytometry as a function of the passage number. The en-
forced expression of YB-1–GFP conferred on YB-1/ cells a
significant proliferation advantage over nonexpressing cells
(Fig. 5E). The expression of GFP alone had no effect on
cellular proliferation under identical conditions. The rescue of
early senescence in YB-1–GFP-expressing YB-1/ cells (but
not in their GFP-expressing counterparts) was also confirmed
by monitoring the total cell growth at the end of each passage
(data not shown).
A microscopic analysis revealed that most passage 4 YB-
1/ cells expressing YB-1–GFP adopted a small and light-
refractile morphology typical of proliferating cells (Fig. 5F,
YB-1–GFP, /, arrows), similar to the morphology of wild-
type cells (Fig. 5F, GFP, /, arrows). This morphology con-
trasted with the flattened, senescent phenotype displayed by
nonexpressing cells (Fig. 5F, YB-1–GFP, /, arrowheads)
and GFP YB-1/ cultures (Fig. 5F, GFP,/, arrowheads).
These results, reproduced with four independent MEF prep-
arations from individual YB-1/ embryos, collectively suggest
that the premature senescence observed in oxidatively stressed
YB-1/ MEFs is due to the YB-1 deficiency per se and not to
a “neighborhood effect” caused by the retained PGK-neo cas-
sette.
Several regulatory pathways are altered in stressed YB-1/
MEFs. We next examined the status of various G1 regulatory
and senescence-related proteins in YB-1/ MEFs cultured in
20% O2 for various periods of time. We could not detect
consistent changes in the protein levels of p53, p19Arf, or
CDK4 between YB-1/ and wild-type/YB-1/ cells as a func-
tion of the passage number (Fig. 6A and data not shown).
p27Kip1 levels were high in all passage 2 MEFs but declined
more rapidly in continuously passaged YB-1/ cells than in
wild-type or YB-1/ cells. In contrast, the cyclin-dependent
kinase inhibitor p16Ink4a and the p53 transcriptional targets
p21Cip1 and Mdm2 accumulated more rapidly in YB-1/
MEFs. The abundance of p16, p21, and Mdm2 in passage 3
YB-1/ cells (lane 6) was significantly higher than that in
passage 4 wild-type and YB-1/ cells (lanes 7 and 8). The
increased abundance of p16 and p21 was due to increased
levels of their respective mRNAs (Fig. 6B), suggesting that a
transcriptional mechanism(s) is responsible. To determine the
relevance of p16 and p21 overexpression in mediating prema-
ture senescence, we “knocked down” the levels of these pro-
teins in YB-1/ MEFs by using specific siRNAs (Fig. 6C). As
shown in Fig. 6D, the p16 and p21 double knockdown extended
the proliferative capacity of late-passage YB-1/ cells. The
early senescent phenotype of YB-1/ cells was not completely
rescued by the double knockdown of p16 and p21, but not all
cells were transfected and inhibition was incomplete. The dou-
ble knockdown of p16 and p21 also enhanced the proliferation
of wild-type cells, as predicted.
DISCUSSION
We have generated the first loss-of-function mouse model to
study the physiologic roles of YB-1. We found that YB-1 plays
important roles in late-stage embryonic development and is
essential for survival beyond the perinatal stage. The loss of
YB-1 does not cause “global” changes in the transcriptomes or
proteomes of cells freshly isolated from YB-1/ embryos.
However, serially cultured YB-1/ MEFs showed an in-
creased sensitivity to oxidative, genotoxic, and oncogene-in-
duced stresses in vitro. YB-1/ MEFs cultured in 20% O2 lost
the proliferative response to serum stimulation and entered
senescence prematurely; these defects were rescued by reduc-
ing the environmental O2 to 3% or by ectopically expressing
human YB-1 cDNA. We further showed that a YB-1 deficiency
results in a premature accumulation of the G1-specific cdk
inhibitors p16Ink4a and p21Cip1 in cells undergoing early se-
nescence. Knocking down the levels of these cell cycle inhibi-
tors partially rescued the senescent phenotype of YB-1/ cells
under oxidative stress.
Our data revealed that YB-1 deficiency results in fully pen-
etrant late embryonic runting and perinatal lethality. Morpho-
logical and histological analyses revealed that many YB-1/
embryos displayed major developmental defects (neurological
abnormalities, hemorrhage, and respiratory failure) that prob-
ably contributed to lethality. Growth retardation occurred in
all late-stage embryos and was the result of hypoplasia in
multiple organ systems. Since late-stage embryogenesis in-
volves massive cellular proliferation that occurs over a very
short period of time, the late embryonic period can be thought
of as a time of considerable proliferative stress. The multiorgan
hypoplasia observed in YB-1/ embryos may therefore occur
because of defective stress response signaling pathways in the
constituent cells. This hypothesis is also consistent with the
observation that YB-1 expression is elevated in many cell lines
in response to various environmental stresses (see below). An
alternative explanation for the late embryonic hypoplasia is a
placental defect caused by YB-1 deficiency. This explanation
seems unlikely to us, however; although YB-1/ placentas
were noted to be slightly smaller than those of wild-type con-
trols, they did not display any of the abnormalities associated
with placental failure (26). To formally rule out of this possi-
bility, a conditional knockout approach with adult mice would
be required.
Numerous in vitro studies have implicated YB-1 in impor-
tant cellular functions such as protein synthesis, mRNA stabi-
lization, cell cycle regulation, and cell survival. Two previous
reports of targeted YB-1 mutations in cultured cell lines (for
both, only YB-1/ cells were established) have suggested that
haploinsufficient phenotypes exist. Guntaka and colleagues
showed that a chicken lymphoid DT40 cell line heterozygous
for a YB-1 targeted mutation displayed major cellular defects,
such as aneuploidy and severe apoptosis (33). Kuwano’s group
found that the disruption of one allele of the YB-1 gene in a
mouse ES cell line caused an abnormal sensitivity to external
cytotoxic stimuli (28). In contrast with these studies, we showed
that YB-1/ mice and MEF preparations have no detectable
phenotype. The mechanisms for the discrepancies among these
mutations are currently unknown, but the two mutant alleles
described in the previous studies could have potentially en-
coded truncated proteins that may have acted as dominant-
negative molecules. Regardless, it is clear that heterozygosity
for our “true null” mutation of YB-1 supports all of the normal
physiological functions of this protein in vivo.
Based on the observation of Evdokimova et al. (10) that
immunodepletion of YB-1 results in a complete inhibition of
protein synthesis in a rabbit reticulocyte lysate, we expected
that a loss of YB-1 would not be compatible with cell viability.
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However, our studies with YB-1-deficient mice revealed that a
high percentage of mouse embryos develop and survive to the
late stage of embryogenesis. Furthermore, we detected “wild-
type” numbers of apoptotic cells in YB-1-deficient embryos
and cultured MEFs. These results strongly suggest that YB-1 is
not a cell viability factor or a bona fide cell cycle regulator. We
further showed that the loss of YB-1 does not cause “global”
changes in the transcriptome, the proteome, or the rate of total
protein synthesis in freshly isolated MEFs. These findings,
while surprising, raise the possibility that other Y-box proteins
may substitute for YB-1 to “rescue” these activities. Three
Y-box proteins, YB-1, MSY2, and MSY4 (13, 35), have been
FIG. 6. Multiple cell cycle regulatory proteins are altered in YB-1/ MEFs cultured in 20% O2. (A) Western analysis of whole-cell lysates from
MEFs of each genotype at passages 2, 3, and 4. -Actin was used as a loading control. (B) Real-time quantitative RT-PCR analysis of p16 and
p21 mRNA expression in wild-type and YB-1/ cells. (C) Diagram of siRNA transfection protocol. (D) Western analysis of whole-cell lysates from
wild-type and YB-1/ cells 2 days after transfection with a random (RN), p16Ink4a, p21Cip1, or p16Ink4a/p21Cip1 siRNA (left). The right panels
show the cumulative growth of two wild-type and four YB-1/ MEF preparations transfected with a random (RN), p16Ink4a, p21Cip1, or
p16Ink4a/p21Cip siRNA. *, nonspecific band used to predict the position of YB-1.
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identified in mice, and their orthologues are known from Xe-
nopus to humans (4, 14). In mice, YB-1 and MSY4 are ubiq-
uitously expressed throughout development. In addition to the
highly conserved central CSD, all vertebrate Y-box proteins
contain a short and variable amino-terminal domain and a long
structurally conserved carboxyl tail consisting of four basic/
aromatic islands. Y-box paralogues have been shown to pos-
sess similar biochemical properties in vitro (reference 13 and
references therein). Regardless of these observations, YB-1 is
required for normal late embryonic development and viability
and for normal responses to cellular stresses; it clearly has
nonredundant functions that are not compensated for by
MSY4. YB-1 is distinct from other CSD family members be-
cause its exceptionally high degree of phylogenetic conserva-
tion occurs not only in the CSD but also in the rest of the
molecule. Alternatively, YB-1 and MSY4 may perform similar
functions in vivo but differ mainly in their tissue distribution
patterns. For example, YB-1 mRNA levels are very high in
human fetal brains, where MSY4 is minimally expressed (32).
The observation that neurological development is sometimes
adversely affected by YB-1 deficiency (i.e., partially penetrant
neural tube defects and exencephaly) therefore suggests that
YB-1 may have important functions in central nervous system
development. In order to better understand the functional
similarities and differences among Y-box paralogues in vivo, it
will be important to compare loss-of-function models of MSY2
and MSY4 with that of YB-1.
Primary MEFs proliferate only for a finite duration in vitro
before irreversibly entering into a nonproliferative state called
culture shock, stasis, or stress-induced senescence. Campisi
and colleagues recently showed that MEFs senesce as a result
of the oxidative stress imposed by culturing in 20% O2, which
is a condition used for standard tissue culture protocols (24).
In addition, a variety of cytotoxic stimuli, including UV and
ionizing irradiation, anticancer drug treatments, and oncogenic
viral infections, have also been shown to trigger senescence
both in vitro and in vivo (3). These findings have suggested that
stress-related senescence may represent one of the tumor-
suppressive mechanisms of somatic cells (24). Interestingly,
many of the same cytotoxic stimuli that trigger senescence are
also known to induce the overexpression and/or nuclear accu-
mulation of YB-1 (2, 8, 17, 25, 30). In the present study, we
found that YB-1/ MEFs cultured in 20% O2 prematurely
senesce and have a reduced proliferative response to serum
stimulation. In addition, YB-1/ MEFs are abnormally sensi-
tive to genotoxic drugs (mitomycin C and cisplatin) and display
a reduced ability to support the accelerated proliferation
caused by oncogene overexpression. Our data therefore pro-
vide an important line of genetic evidence showing that YB-1
is an important component of a cellular stress response signal-
ing pathway that is required to protect cells from a variety of
stresses.
We do not yet know how YB-1 protects cells from senes-
cence. However, late-passage YB-1/ MEFs displayed a high
percentage of cells in G0/G1 and prematurely accumulated the
negative cell cycle regulators p16Ink4a and p21Cip1. These
findings are consistent with the view that cell cycle arrest is an
important step towards the initiation of the senescent pheno-
type (3). As a transcription factor, YB-1 has been described to
regulate (both positively and negatively) a host of target genes
involved in the stress response pathway and in cell growth
(references 2, 28, and 29 and references therein). However, it
remains to be established whether YB-1 plays a direct role in
negatively regulating p16Ink4a and p21Cip1 transcription in
oxidatively stressed MEFs. In addition, YB-1 could also di-
rectly interact with other important cytotoxic stress-related
factors and modulate their biological activities. YB-1 has pre-
viously been shown to physically interact with p53 both in vitro
and in vivo (23, 37). The p53/Mdm2/p19Arf pathway plays an
integral role in the cellular stress response, genomic integrity
surveillance, and senescence pathways. While our results do
not suggest that the early senescent phenotype is caused by
FIG. 7. Model of YB-1 function. Many environmental insults or cellular proliferation signals induce the expression and nuclear accumulation
of YB-1 in mammalian cells. YB-1 is an integral part of a general cellular stress response signaling pathway required for protecting cells from a
variety of stresses. The loss of YB-1 causes the loss of this protective mechanism. Consequently, cells deficient in YB-1 show an increased sensitivity
to environmental stresses, leading to premature senescence.
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disregulation of p53 or p19ARF gene expression, YB-1 may still
play a role in this pathway by altering p53 or p19Arf activities.
Indeed, two p53 transcriptional target genes (p21Cip1 and
Mdm2) are prematurely induced in YB-1/ MEFs, suggesting
that p53 activity does indeed increase with a YB-1 deficiency.
Alternatively, YB-1 has been shown to exhibit high affinities
for damaged DNA (apurinic or cisplatin- or UV-modified
DNA) and H-DNA structures, and it physically interacts with
several DNA repair factors in genotoxically stressed cells
(references 12 and 22 and references therein), raising the pos-
sibility that YB-1 may function directly in DNA damage rec-
ognition and/or processing. The loss of murine Fus/TLS, a
YB-1-interacting multifunctional ribonucleoprotein, has been
shown to cause chromosomal instability and perinatal death
(16). Many mouse mutants lacking genes important for DNA
repair pathways (e.g., Xrcc2, Lig4, Xrcc4, Ku70/80, Pol, and
Xpa) also result in a premature senescence phenotype (refer-
ences 3 and 24 and references therein). Recent clinical studies
have also reported a strong correlation between the nuclear
level of YB-1 and the cellular resistance to chemotherapy of
various primary human cancers (reviewed in reference 12). We
are therefore using our YB-1-deficient mice to investigate the
importance of YB-1 for DNA repair, genome stability, and the
genetic interaction with the p53 pathway (Fig. 7).
In conclusion, our data have revealed that YB-1 is required
for the normal late embryonic development and survival of
mice, and they suggest that YB-1 is a cellular stress response
factor that is important for preventing the early onset of se-
nescence in cultured cells in vitro. These data raise the possi-
bility that the overexpression of YB-1 may contribute to trans-
formation by protecting cells that are rapidly proliferating.
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